Literature DB >> 21401418

Retinoic acid receptor γ-dependent signaling cooperates with BMP2 to induce osteoblastic differentiation of C2C12 cells.

Takeo Karakida1, Ryogo Yui, Toshiaki Suzuki, Makoto Fukae, Shinichiro Oida.   

Abstract

All-trans retinoic acid and bone morphogenetic protein 2 (BMP2) synergistically induced an alkaline phosphatase (ALP) activity, one of the osteoblastic differentiation markers, and promoted the extracellular matrix calcification in a myoblastic C2C12 cell culture system. The induced ALP mRNA was not suppressed in the presence of a protein synthesis inhibitor, suggesting that the de novo protein synthesis does not influence this induction. There are three isotypes for the retinoic acid receptor (RARα, RARβ, RARγ). Both the ALP activity and the extracellular matrix calcification were inhibited by the addition of the specific siRNA for RARγ, but not by that for RARα or RARβ. When the effects of the RAR subtype-specific agonists on the ALP activity in the presence of BMP2 were examined, the RARγ-specific agonist was the most effective. The ALP activity induced by any RAR subtype-specific agonist was inhibited by the addition of the specific siRNA for RARγ, but not by that for RARα or RARβ. These results suggest that a RARγ-dependent functional crosstalk is present between the retinoic acid and BMP2 signaling to induce osteogenic transdifferentiation in myoblastic C2C12 cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21401418     DOI: 10.3109/03008207.2010.541309

Source DB:  PubMed          Journal:  Connect Tissue Res        ISSN: 0300-8207            Impact factor:   3.417


  3 in total

1.  Heterodimeric BMP-2/7 antagonizes the inhibition of all-trans retinoic acid and promotes the osteoblastogenesis.

Authors:  Wenjuan Bi; Zhiyuan Gu; Yuanna Zheng; Xiao Zhang; Jing Guo; Gang Wu
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

2.  All-trans retinoic acid can antagonize osteoblastogenesis induced by different BMPs irrespective of their dimerization types and dose-efficiencies.

Authors:  Yi Liu; Xiaoqing Ma; Jing Guo; Zhen Lin; Miao Zhou; Wenjuan Bi; Jinsong Liu; Jingxiao Wang; Haiping Lu; Gang Wu
Journal:  Drug Des Devel Ther       Date:  2018-10-10       Impact factor: 4.162

3.  The Antagonist of Retinoic Acid Receptor α, ER-50891 Antagonizes the Inhibitive Effect of All-Trans Retinoic Acid and Rescues Bone Morphogenetic Protein 2-Induced Osteoblastogenic Differentiation.

Authors:  Siqian Wang; Wenjuan Bi; Yi Liu; Jiayi Cheng; Wei Sun; Gang Wu; Xin Xu
Journal:  Drug Des Devel Ther       Date:  2020-01-22       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.